DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD) today announced third quarter of fiscal 2008 revenue of $16.0 million, up 24% compared to revenue of $12.9 million for the same period of fiscal 2007. Total revenue for the third quarter of fiscal 2008 was the highest in Abiomed history, and the Company announced that revenue in both the U.S. and Europe were also record highs for a quarter. Revenue for the nine months ended December 31, 2007 was $41.4 million, up 13% compared to revenue of $36.8 million in the first nine months of fiscal 2007.
